Genetic variability in CYP3A4 and CYP3A5in primary liver, gastric and colorectal cancer patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Genetic variability in CYP3A4 and CYP3A5in primary liver, gastric and colorectal cancer patients ; volume:7 ; number:1 ; day:02 ; month:7 ; year:2007 ; pages:1-7 ; date:12.2007
BMC cancer ; 7, Heft 1 (02.7.2007), 1-7, 12.2007

Creator: Gervasini, Guillermo

Contributor: García-Martín, Elena
Ladero, José M.
Pizarro, Rosa
Sastre, Javier
Martínez, Carmen
García, Monserrat
Diaz-Rubio, Manuel
Agundez, José
SpringerLink (Online service)

DOI: 10.1186/1471-2407-7-118

URN: urn:nbn:de:1111-2016030344532

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Gervasini, Guillermo
García-Martín, Elena
Ladero, José M.
Pizarro, Rosa
Sastre, Javier
Martínez, Carmen
García, Monserrat
Diaz-Rubio, Manuel
Agundez, José
SpringerLink (Online service)

Other Objects (12)

CYP3A4 and CYP3A5genotyping by Pyrosequencing

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation : insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Antivirals and nuclear receptor activation of CYP3A4 and 2B6

Myricetin inhibits CYP3A4, GST, and MRP1 in hepatic cancer cells

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1and colorectal cancer risk

Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies

CYP3A4 drug metabolism considerations in pediatric pharmacotherapy

Selective expression of KCNA5 and KCNB1 genes in gastric and colorectal carcinoma

Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

Hochschulschrift

Individualizing simvastatin dose with respect to CYP3A4 activity

Hochschulschrift

Polymorphismen in der Promoter- und Enhancerregion von CYP3A4

CYP3A4 and CYP3A5genotyping by Pyrosequencing

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation : insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Antivirals and nuclear receptor activation of CYP3A4 and 2B6

Myricetin inhibits CYP3A4, GST, and MRP1 in hepatic cancer cells

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1and colorectal cancer risk

Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies

CYP3A4 drug metabolism considerations in pediatric pharmacotherapy

Selective expression of KCNA5 and KCNB1 genes in gastric and colorectal carcinoma

Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

Hochschulschrift

Individualizing simvastatin dose with respect to CYP3A4 activity

Hochschulschrift

Polymorphismen in der Promoter- und Enhancerregion von CYP3A4

CYP3A4 and CYP3A5genotyping by Pyrosequencing

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation : insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Antivirals and nuclear receptor activation of CYP3A4 and 2B6

Myricetin inhibits CYP3A4, GST, and MRP1 in hepatic cancer cells

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1and colorectal cancer risk

Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies

CYP3A4 drug metabolism considerations in pediatric pharmacotherapy

Selective expression of KCNA5 and KCNB1 genes in gastric and colorectal carcinoma

Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

Hochschulschrift

Individualizing simvastatin dose with respect to CYP3A4 activity

Hochschulschrift

Polymorphismen in der Promoter- und Enhancerregion von CYP3A4

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Genetic variability in CYP3A4 and CYP3A5in primary liver, gastric and colorectal cancer patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

CYP3A4 and CYP3A5genotyping by Pyrosequencing

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation : insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Antivirals and nuclear receptor activation of CYP3A4 and 2B6

Myricetin inhibits CYP3A4, GST, and MRP1 in hepatic cancer cells

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1and colorectal cancer risk

Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies

CYP3A4 drug metabolism considerations in pediatric pharmacotherapy

Selective expression of KCNA5 and KCNB1 genes in gastric and colorectal carcinoma

Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

Individualizing simvastatin dose with respect to CYP3A4 activity

Polymorphismen in der Promoter- und Enhancerregion von CYP3A4

CYP3A4 and CYP3A5genotyping by Pyrosequencing

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation : insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Antivirals and nuclear receptor activation of CYP3A4 and 2B6

Myricetin inhibits CYP3A4, GST, and MRP1 in hepatic cancer cells

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1and colorectal cancer risk

Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies

CYP3A4 drug metabolism considerations in pediatric pharmacotherapy

Selective expression of KCNA5 and KCNB1 genes in gastric and colorectal carcinoma

Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

Individualizing simvastatin dose with respect to CYP3A4 activity

Polymorphismen in der Promoter- und Enhancerregion von CYP3A4

CYP3A4 and CYP3A5genotyping by Pyrosequencing

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation : insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4

Antivirals and nuclear receptor activation of CYP3A4 and 2B6

Myricetin inhibits CYP3A4, GST, and MRP1 in hepatic cancer cells

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1and colorectal cancer risk

Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies

CYP3A4 drug metabolism considerations in pediatric pharmacotherapy

Selective expression of KCNA5 and KCNB1 genes in gastric and colorectal carcinoma

Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

Individualizing simvastatin dose with respect to CYP3A4 activity

Polymorphismen in der Promoter- und Enhancerregion von CYP3A4

Related objects

Reset password